"The dollar's getting weak, and people are starting to realize that," said Jim Cramer on Monday's "Stop Trading!" segment on CNBC.
Cramer's weak-dollar play in the health care sector is
. "That's the one that I think has the best mojo on a down-103 day," he said.
Today, Goldman Sachs downgraded "everything," said Cramer, even
. "It's incredible," said Cramer. "The
futures were flying this morning. I guess people thought that the Apple downgraded was not going to affect Apple?"
Goldman also downgraded
, lowering its price target on the stock from $33 to $30. "The stock's at $26," said Cramer. "That's a downgrade?"
"They're just looking for something to do at Goldman," Cramer said. "Goldman Sachs is just out there."
At the time of publication, Cramer was long Goldman Sachs.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for
Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click
here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click
here to order his book, "Real Money: Sane Investing in an Insane World," click
here to get his second book, "You Got Screwed!" and click
here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by
TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.